Targeted Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.1 | Q1 | 75.4% | 1.435 | Q1 | 91.4% |
| 2024 | 4.0 | Q2 | 70.6% | 1.645 | Q1 | 93.3% |
| 2023 | 4.4 | Q2 | 70.6% | 1.421 | Q1 | 91.9% |
| 2022 | 5.4 | Q2 | 74.6% | 1.460 | Q1 | 92.7% |
| 2021 | 4.9 | Q2 | 65.1% | 1.233 | Q1 | 90.4% |
| 2020 | — | — | 1.697 | Q1 | 93.9% | |
| 2019 | — | — | 1.442 | Q1 | 92.1% | |
| 2018 | — | — | 1.322 | Q1 | 89.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1776-2596
ISSN
1776-260X
country
CHcoverage
2006-2026